{"id":"abx464-repeated-dose","safety":{"commonSideEffects":[{"rate":"10%","effect":"Nausea"},{"rate":"8%","effect":"Headache"},{"rate":"5%","effect":"Diarrhea"}]},"_chembl":{"chemblId":"CHEMBL4297344","moleculeType":"Small molecule","molecularWeight":"338.72"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"ABX464 acts by binding to the retinoic acid receptor gamma (RARγ), thereby modulating the immune response and reducing inflammation.","oneSentence":"ABX464 is a small molecule antagonist of RARγ","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T04:51:54.901Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Treatments for autoimmune diseases"}]},"trialDetails":[{"nctId":"NCT02731885","phase":"PHASE1","title":"Food Effect on Pharmacokinetic Parameters of ABX464","status":"COMPLETED","sponsor":"Abivax S.A.","startDate":"2014-09","conditions":"Healthy Volunteers","enrollment":48}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_1","status":"active","brandName":"ABX464 Repeated dose","genericName":"ABX464 Repeated dose","companyName":"Abivax S.A.","companyId":"abivax-s-a","modality":"Small molecule","firstApprovalDate":"","aiSummary":"ABX464 is a small molecule that modulates the cap binding complex, classified as a modulator. It was studied in a clinical trial (NCT02731885) involving healthy volunteers to investigate its pharmacokinetic parameters after single and repeated doses.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}